Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Distance-Dependent Structure and Function of Neuronal Dendrites
Biological & Physiological Determinants of Behavior
Phase I Clinical Trials of Anti-Cancer Agents
Cost-Effectiveness Analysis of Micronutrient Supplementa
Dorsal-Ventral Pattern of the Drosophila Embryo
Recently added grants:
Targeting ACE2 ubiquitination for hypertension
Highly Multiplexed Cell-Based GPCR Assay.
Leptin in HIV associated vascular diseases
University of Washington ENDURE
Identifying Modifiable Risk and Protective Processes at the Day-Level that Predict HIV Care Outcomes Among Women Exposed to Partner Violence
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07151-17-0-1
Application #
7574820
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Duke University
$270,293
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
Thornburg, Courtney /
$292,009
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
NIH 2007
N01 HL
/
Comments
Be the first to comment on this grant